Hyponatremia in Congestive Heart Failure (CHF): Harnessing the Horse with Tolvaptan
Pakistan Journal of Kidney Diseases · 31.03.2026 · 10 (1) · 3-9
DOI: 10.53778/pjkd101350 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pakistan Journal of Kidney Diseases, online erschienen am 31.03.2026. Verfasst von Chaudhry Adeel Ebad. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Hyponatremia in Congestive Heart Failure (CHF) is a complex and ominous clinical entity that transcends simple electrolyte imbalance. It serves as a profound indicator of advanced neurohormonal derangement and stands as one of the most reliable predictors of morbidity and mortality in the heart failure population [12, 20]. While traditional loop diuretics remain the cornerstone of decongestion, they frequently exacerbate hyponatremia by causing natriuresis and further activating the renin-angiotensin-aldosterone system (RAAS), leading to a state of "diuretic resistance" [5, 15]. Tolvaptan—an oral, selective vasopressin V_2-receptor antagonist—offers a physiologically targeted alternative. By inducing "aquaresis" (the excretion of solute-free water) rather than natriuresis, tolvaptan allows clinicians to "harness" the runaway vasopressin response [7, 18]. This article provides a comprehensive exploration of the pathophysiology of hypervolemic hyponatremia, the foundational clinical evidence supporting vaptan therapy, and a structured, safe approach to managing these high-risk patients
Zitieren
APA
Ebad, C. A. (2026). Hyponatremia in Congestive Heart Failure (CHF): Harnessing the Horse with Tolvaptan. Pakistan Journal of Kidney Diseases, 10(1), 3-9. https://doi.org/10.53778/pjkd101350
Vancouver
Ebad CA. Hyponatremia in Congestive Heart Failure (CHF): Harnessing the Horse with Tolvaptan. Pakistan Journal of Kidney Diseases. 2026;10(1):3-9. doi:10.53778/pjkd101350
BibTeX
@article{Ebad2026,
author = {Ebad, Chaudhry Adeel},
title = {Hyponatremia in Congestive Heart Failure (CHF): Harnessing the Horse with Tolvaptan},
journal = {Pakistan Journal of Kidney Diseases},
year = {2026},
volume = {10},
number = {1},
pages = {3--9},
doi = {10.53778/pjkd101350}
}
EUVIMED